Members of our team had the opportunity to present a new poster abstract at NASP inSPIRE 2026, which was held from September 22-25, 2026.
Authors
Ruhama Mengesha, BS (PharmD Candidate); Andrew Wash, PharmD, PhD; Ana Lopez-Medina, PharmD, PhD; Casey Fitzpatrick, PharmD
Background
-
Health-system specialty pharmacies (HSSPs) provide high-touch care with ongoing patient engagement, enabling pharmacists to identify and address issues early, either independently or in collaboration with prescribers.1
-
While pharmacist-led interventions are known to improve clinical outcomes, treatment persistence, and drug adherence, little is known about when those interventions occur during the medication journey.2,3
-
Understanding the timing of pharmacist interventions could help develop more proactive and targeted strategies to optimize patient care.
Objectives
To describe when pharmacist interventions occur across predefined timing windows following therapy initiation.
-
1
Kibbons AM, Moore R, Choi L, Zuckerman AD, et al. Patient-tailored interventions to improve specialty medication adherence: results from a prospective randomized controlled trial. Am J Med. 2023;136(7):694-791.
-
2
St James GJ, Duckworth DL, Bochenek SH, et al. Effect on medication adherence of applying a specialty pharmacy care model to nonspecialty medications. Am J Health Syst Pharm. 2023;80(Suppl 4):S135-S142.
-
3
Smith-Ray R, Feng L, Singh T, et al. Pharmacists as clinical care partners: how a pharmacist-led intervention is associated with improved medication adherence in older adults with common chronic conditions. J Manag Care Spec Pharm. 2024;30(4):345-351.
